×
About 3,209 results

ALLMedicine™ Peptic Ulcer Disease Center

Research & Reviews  1,495 results

Anti-inflammatory activity of 2-((3-(chloromethyl)benzoyl)oxy)benzoic acid in LPS-induc...
https://doi.org/10.1016/j.prostaglandins.2021.106549
Prostaglandins & Other Lipid Mediators; Tjahjono Y, Karnati S et. al.

Apr 8th, 2021 - Salicylic acid derivate is very popular for its activity to suppress pain, fever, and inflammation. One of its derivatives is acetylsalicylic acid (ASA) which has been reported repeatedly that, as a non-steroidal anti-inflammatory drug (NSAID), it...

Management of Non-Variceal Upper GI Bleeding in the Geriatric Population: An Update.
https://doi.org/10.1007/s11894-021-00805-6 10.3111/13696990903526676 10.1007/s10620-017-4882-6 10.1016/j.gie.2013.04.161 10.1111/j.1572-0241.2001.03455.x 10.21037/atm.2017.01.10 10.1016/j.amjcard.2019.05.008 10.1155/2006/859435 10.3748/wjg.14.4047 10.3109/00365521.2012.763174 10.1177/1756283X15614517 10.1016/S0140-6736(00)02816-6 10.1016/j.gie.2011.06.024 10.1016/j.gie.2015.10.021 10.20524/aog.2016.0096 10.1016/j.gie.2015.09.035 10.1182/bloodadvances.2018024893 10.1371/journal.pone.0183423 10.1161/CIRCULATIONAHA.113.004747 10.1161/CIRCULATIONAHA.108.191087 10.1016/j.cgh.2016.07.017 10.1007/s40266-014-0173-5 10.1007/s40266-017-0447-9 10.1155/2018/5257285 10.20524/aog.2016.0045 10.1055/s-0034-1393172 10.7326/0003-4819-127-12-199712150-00002 10.3748/wjg.v25.i22.2720 10.1016/j.dld.2014.04.011 10.1016/j.gie.2017.01.028 10.1016/j.gie.2017.07.018 10.5946/ce.2014.47.2.135 10.1016/j.cger.2013.10.010 10.1016/j.clinthera.2015.10.005 10.1016/j.clinthera.2019.06.011 10.1016/j.gie.2019.12.047 10.1097/MD.0000000000008439 10.1056/NEJMoa1912484 10.1016/j.gie.2015.09.035 10.4253/wjge.v11.i2.68 10.1016/j.gie.2011.11.041 10.1016/j.ijge.2017.04.003 10.1016/j.rgmx.2017.08.004 10.3748/wjg.v23.i4.697 10.3748/wjg.v18.i36.5051 10.4103/sjg.SJG_415_19 10.1055/a-0576-0566 10.1177/0300060516645420 10.1159/000499678 10.5009/gnl16330 10.1097/MCG.0000000000000274 10.1016/j.rgmxen.2017.08.001 10.1007/s10620-014-3178-3
Current Gastroenterology Reports; Stolow E, Moreau C et. al.

Mar 26th, 2021 - Upper gastrointestinal (GI) bleeding is a significant cause of morbidity and mortality in the geriatric (age > 65 years) population and presents a unique management challenge in the context of multiple medical comorbidities, polypharmacy, and incr...

Non-steroidal anti-inflammatory drugs and the gastrointestinal tract.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002800
Clinical Medicine (London, England); Tai FWD, McAlindon ME

Mar 25th, 2021 - Non-steroidal anti-inflammatory drugs (NSAIDs) are used commonly but can cause foregut symptoms, peptic ulcer disease and small bowel enteropathy. Such iatrogenic injury can be complicated by gastrointestinal bleeding and perforation. Limiting NSA...

Exploiting drug delivery systems for oral route in the peptic ulcer disease treatment.
https://doi.org/10.1080/1061186X.2021.1904249
Journal of Drug Targeting; Spósito L, Fortunato GC et. al.

Mar 17th, 2021 - Peptic ulcer disease (PUD) is a common condition that is induced by acid and pepsin causing lesions in the mucosa of the duodenum and stomach. The pathogenesis of PUD is a many-sided scenario, which involves an imbalance between protective factors...

see more →

Guidelines  13 results

Perforated and bleeding peptic ulcer: WSES guidelines.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947898
World Journal of Emergency Surgery : WJES; Tarasconi A, Coccolini F et. al.

Jan 10th, 2020 - Peptic ulcer disease is common with a lifetime prevalence in the general population of 5-10% and an incidence of 0.1-0.3% per year. Despite a sharp reduction in incidence and rates of hospital admission and mortality over the past 30 years, compli...

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
https://doi.org/10.1038/ajg.2016.563
The American Journal of Gastroenterology; Chey WD, Leontiadis GI et. al.

Jan 10th, 2017 - Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important cause of peptic ulcer disease and gastric cancer. H. pylori may also have a role in uninvestigated and functional dyspepsia, ulcer risk in patients taki...

Treatment of Helicobacter pylori Infection: ACG Guidelines
http://gi.org/guideline/treatment-of-helicobacter-pylori-infection/
Chey WC

Jan 9th, 2017 - Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important cause of peptic ulcer disease and gastric cancer.

Evidence-based clinical practice guidelines for peptic ulcer disease 2015.
https://doi.org/10.1007/s00535-016-1166-4
Journal of Gastroenterology; Satoh K, Yoshino J et. al.

Feb 17th, 2016 - The Japanese Society of Gastroenterology (JSGE) revised the evidence-based clinical practice guidelines for peptic ulcer disease in 2014 and has created an English version. The revised guidelines consist of seven items: bleeding gastric and duoden...

Quality indicators for EGD
https://www.asge.org/docs/default-source/education/practice_guidelines/doc-b68366e5-03fd-429d-8150-77193bec8873.pdf?sfvrsn=6
Walter G. Park

Nov 30th, 2014 - EGD is used widely for the diagnosis and treatment of esophageal, gastric, and small-bowel disorders. When properly performed, it is generally safe and well-tolerated for the examination of the upper GI tract.

see more →

Drugs  4 results see all →

Clinicaltrials.gov  1,583 results

Anti-inflammatory activity of 2-((3-(chloromethyl)benzoyl)oxy)benzoic acid in LPS-induc...
https://doi.org/10.1016/j.prostaglandins.2021.106549
Prostaglandins & Other Lipid Mediators; Tjahjono Y, Karnati S et. al.

Apr 8th, 2021 - Salicylic acid derivate is very popular for its activity to suppress pain, fever, and inflammation. One of its derivatives is acetylsalicylic acid (ASA) which has been reported repeatedly that, as a non-steroidal anti-inflammatory drug (NSAID), it...

Management of Non-Variceal Upper GI Bleeding in the Geriatric Population: An Update.
https://doi.org/10.1007/s11894-021-00805-6 10.3111/13696990903526676 10.1007/s10620-017-4882-6 10.1016/j.gie.2013.04.161 10.1111/j.1572-0241.2001.03455.x 10.21037/atm.2017.01.10 10.1016/j.amjcard.2019.05.008 10.1155/2006/859435 10.3748/wjg.14.4047 10.3109/00365521.2012.763174 10.1177/1756283X15614517 10.1016/S0140-6736(00)02816-6 10.1016/j.gie.2011.06.024 10.1016/j.gie.2015.10.021 10.20524/aog.2016.0096 10.1016/j.gie.2015.09.035 10.1182/bloodadvances.2018024893 10.1371/journal.pone.0183423 10.1161/CIRCULATIONAHA.113.004747 10.1161/CIRCULATIONAHA.108.191087 10.1016/j.cgh.2016.07.017 10.1007/s40266-014-0173-5 10.1007/s40266-017-0447-9 10.1155/2018/5257285 10.20524/aog.2016.0045 10.1055/s-0034-1393172 10.7326/0003-4819-127-12-199712150-00002 10.3748/wjg.v25.i22.2720 10.1016/j.dld.2014.04.011 10.1016/j.gie.2017.01.028 10.1016/j.gie.2017.07.018 10.5946/ce.2014.47.2.135 10.1016/j.cger.2013.10.010 10.1016/j.clinthera.2015.10.005 10.1016/j.clinthera.2019.06.011 10.1016/j.gie.2019.12.047 10.1097/MD.0000000000008439 10.1056/NEJMoa1912484 10.1016/j.gie.2015.09.035 10.4253/wjge.v11.i2.68 10.1016/j.gie.2011.11.041 10.1016/j.ijge.2017.04.003 10.1016/j.rgmx.2017.08.004 10.3748/wjg.v23.i4.697 10.3748/wjg.v18.i36.5051 10.4103/sjg.SJG_415_19 10.1055/a-0576-0566 10.1177/0300060516645420 10.1159/000499678 10.5009/gnl16330 10.1097/MCG.0000000000000274 10.1016/j.rgmxen.2017.08.001 10.1007/s10620-014-3178-3
Current Gastroenterology Reports; Stolow E, Moreau C et. al.

Mar 26th, 2021 - Upper gastrointestinal (GI) bleeding is a significant cause of morbidity and mortality in the geriatric (age > 65 years) population and presents a unique management challenge in the context of multiple medical comorbidities, polypharmacy, and incr...

Non-steroidal anti-inflammatory drugs and the gastrointestinal tract.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002800
Clinical Medicine (London, England); Tai FWD, McAlindon ME

Mar 25th, 2021 - Non-steroidal anti-inflammatory drugs (NSAIDs) are used commonly but can cause foregut symptoms, peptic ulcer disease and small bowel enteropathy. Such iatrogenic injury can be complicated by gastrointestinal bleeding and perforation. Limiting NSA...

Exploiting drug delivery systems for oral route in the peptic ulcer disease treatment.
https://doi.org/10.1080/1061186X.2021.1904249
Journal of Drug Targeting; Spósito L, Fortunato GC et. al.

Mar 17th, 2021 - Peptic ulcer disease (PUD) is a common condition that is induced by acid and pepsin causing lesions in the mucosa of the duodenum and stomach. The pathogenesis of PUD is a many-sided scenario, which involves an imbalance between protective factors...

see more →

News  111 results

Large prospective trial offers reassurance for long-term PPI use
https://www.mdedge.com/gihepnews/article/205801/upper-gi-tract/large-prospective-trial-offers-reassurance-long-term-ppi-use/page/0/1?channel=347

Aug 2nd, 2019 - Most patients in the trial (78%) were male, and 23% were current smokers. Smaller proportions of the population were taking an NSAID (5%) and/or had a history of peptic ulcer disease (2.

July 2019 - Question 2
https://www.mdedge.com/gihepnews/article/203785/july-2019-question-2?channel=29259

Jun 28th, 2019 - Q2. Correct answer: C Rationale Oral iron, and not infusions, are associated with peptic ulcer disease.

Can acid suppression prevent recurrent idiopathic gastroduodenal ulcer bleeding?
https://www.mdedge.com/jcomjournal/article/202014/gastroenterology/can-acid-suppression-prevent-recurrent-idiopathic?channel=213
Doug Brunk

May 31st, 2019 - SAN DIEGO – Lansoprazole and famotidine are comparable for the prevention of recurrent ulcer bleeding in patients with a history of Helicobacter pylori–negative idiopathic bleeding ulcers, results from a double-blind, randomized trial showed. Howe.

DDSEP® 8 Quick Quiz Question 2
https://www.mdedge.com/gihepnews/article/197788/ddsepr-8-quick-quiz-question-2

Mar 29th, 2019 - Critique: Factors raising suspicion for Zollinger-Ellison syndrome include recurrent peptic ulcer disease, multiple ulcers, post-bulbar ulcer, non-H. pylori/non-NSAID-related duodenal ulcer, diarrhea, erosive esophagitis, and family or personal hi.

April 2019 - Question 2
https://www.mdedge.com/gihepnews/article/197788/april-2019-question-2?channel=29259

Mar 29th, 2019 - Critique: Factors raising suspicion for Zollinger-Ellison syndrome include recurrent peptic ulcer disease, multiple ulcers, post-bulbar ulcer, non-H. pylori/non-NSAID-related duodenal ulcer, diarrhea, erosive esophagitis, and family or personal hi.

see more →

Patient Education  3 results see all →